Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization

More on Renin–angiotensin system

• RAS inhibitors linked to lower dementia risk than CCBs

  Drugs & Aging · 4 Oct 2026

• H-FABP links to heart risks mostly when omega-3s are low

  Heart · 4 Oct 2026

• ARNI links to lower osteoporosis risk in heart failure

  Internal and Emergency Medicine · 4 Oct 2026

• Cardiometabolic burden is linked to CVD and death in MASLD

  Frontiers in Nutrition · 4 Oct 2026